Eritel B 40mg/50mg Tablet PR

This combination is indicated for the management of essential hypertension, providing complementary mechanisms to achieve effective blood pressure reduction and reduce the risk of cardiovascular events. Eritel B is particularly beneficial in patients requiring dual therapy to attain target blood pressure levels or those with concomitant conditions such as ischemic heart disease or heart failure where beta-blockade is advantageous.

The prolonged-release formulation of Metoprolol Succinate ensures stable plasma concentrations and once-daily dosing, enhancing patient compliance. Caution is advised in patients with bradycardia, heart block, or severe hepatic impairment. Regular monitoring of blood pressure, heart rate, and renal function is recommended during therapy. Eritel B should be used under medical supervision with adherence to prescribed dosage to optimize therapeutic outcomes and minimize adverse effects.